It’s been a long time coming, but well worth the wait. Ribapharm Inc., having filed for its initial public offering in June 2000, got the deal done Friday, pricing 26 million shares at $10 apiece, raising $260 million and entering biotechnology’s IPO record book. (BioWorld Today)
Money doesn’t grow on trees, but there’s certainly money to be made by growing better crops. Ceres Inc. signed on to apply its genomics technologies in the quest for improved agricultural harvests with Monsanto Co. in a collaboration that could bring Ceres a bounty of $137 million. (BioWorld Today)
Money doesn’t grow on trees, but there’s certainly money to be made by growing better crops. Ceres Inc. signed on to apply its genomics technologies in the quest for improved agricultural harvests with Monsanto Co. in a collaboration that could bring Ceres a bounty of $137 million. (BioWorld Today)
